The attributes of DWP418-PEG-HER can protect the virus after systemic injection, which subsequently influences in vivo therapeutic efficacy in Her2/neu-positive tumor models (SKOV-3 and MDA-MB435). The gene discussed is ERBB2; the disease is neoplasm.